AstraZeneca
AZN
#44
Rank
A$447.88 B
Marketcap
A$288.90
Share price
-0.47%
Change (1 day)
42.20%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): A$9.21

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is A$8.40. In 2024 the company made an earnings per share (EPS) of A$6.43 an increase over its 2023 EPS that were of A$5.44.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$9.2143.31%
2024A$6.4318.23%
2023A$5.4481.13%
2022A$3.00631.03%
2021A$0.41-88.11%
2020A$3.45136.89%
2019A$1.46-39.41%
2018A$2.41-28.27%
2017A$3.36-14.37%
2016A$3.9224.11%
2015A$3.16127.55%
2014A$1.39-51.96%
2013A$2.89-58.95%
2012A$7.04-32.2%
2011A$10.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.77 87.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.20 21.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.93-77.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.31-36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.60 288.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.92-65.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$12.50 48.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.35 23.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.90-41.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.34-36.46%๐Ÿ‡ฌ๐Ÿ‡ง UK